Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Jun-23 2:30 PM View:  | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 22% 17.75K to 21.61K | |
| 28-Jun-22 1:51 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-22 | Grant | 3,300 | -- | -- | 23% 14.45K to 17.75K | |
| 28-Jun-21 6:23 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-21 | Grant | 2,145 | -- | -- | 17% 12.3K to 14.45K | |
| 30-Jun-20 1:13 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 26-Jun-20 | Grant | 2,550 | -- | -- | 26% 9.75K to 12.3K | |
| 13-Jun-19 4:46 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 11-Jun-19 | Grant | 3,000 | -- | -- | 44% 6.75K to 9.75K | |
| 20-Jun-18 6:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-18 | Grant | 3,000 | -- | -- | 80% 3.75K to 6.75K | |
| 22-Jun-17 7:26 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 22-Jun-17 | Grant | 1,875 | -- | -- | 100% 1.88K to 3.75K | |
| 02-Jun-17 4:55 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 31-May-17 | Grant | 626 | $1.55 | $970.30 | 8% 7.73K to 8.36K | |
| 02-Dec-16 5:11 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-Nov-16 | Grant | 802 | $1.67 | $1,339.34 | 15% 5.51K to 6.31K | |
| 14-Jun-16 5:42 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 09-Jun-16 | Grant | 1,875 | -- | -- | 100% 0 to 1.88K | |
| 02-Jun-16 11:23 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 31-May-16 | Grant | 8,777 | $0.34 | $2,984.18 | 15% 60.51K to 69.28K | |
| 04-Feb-16 12:04 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-Nov-15 | Grant | 1,761 | $2.03 | $3,574.83 | 3% 58.75K to 60.51K | |
| 04-Feb-16 12:04 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-May-15 | Grant | 721 | $4.17 | $3,006.57 | 1% 58.03K to 58.75K | |
| 15-Sep-14 2:41 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 15-Sep-14 | Market Purchase | 50,000 | $4.78 | $239,100.00 | 623% 8.03K to 58.03K | (93%) |
| 06-Feb-14 3:50 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 04-Feb-14 | Purchase | 62,500 | $8.00 | $500,000.00 | 100% 0 to 62.5K | |
| 11-Feb-14 7:32 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Nov-13 | Grant | 3,980 | $5.34 | $21,253.20 | 100% 0 to 3.98K | |
| 24-May-13 7:55 AM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 23-May-13 | Grant | 3,800 | -- | -- | 19% 20.1K to 23.9K | |
| 19-Jul-12 8:07 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 17-Jul-12 | Option Exercise | 150,000 | $1.67 | $250,030.00 | 100% 0 to 150.0K | |
| 19-Jul-12 8:07 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 17-Jul-12 | Market Option Sale (Planned) | 150,000 | $7.66 | $1,149,000.00 | (100%) 150.0K to 0 | 96% |
| 13-Jul-12 8:13 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 13-Jul-12 | Option Exercise | 147,100 | $1.66 | $244,186.00 | 100% 0 to 147.1K | |
| 13-Jul-12 8:13 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 13-Jul-12 | Market Option Sale (Planned) | 147,100 | $6.70 | $985,570.00 | (100%) 147.1K to 0 | 95% |
| 13-Jul-12 8:13 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 12-Jul-12 | Option Exercise | 2,900 | $1.66 | $4,814.00 | 100% 0 to 2.9K | |
| 13-Jul-12 8:13 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 12-Jul-12 | Market Option Sale (Planned) | 2,900 | $6.66 | $19,314.00 | (100%) 2.9K to 0 | 95% |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Jun-12 | Option Exercise | 125,000 | $1.66 | $207,500.00 | 100% 0 to 125.0K | |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Jun-12 | Market Option Sale (Planned) | 125,000 | $6.08 | $760,000.00 | (100%) 125.0K to 0 | 95% |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Jun-12 | Option Exercise | 100,000 | $1.66 | $166,000.00 | 100% 0 to 100.0K | |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Jun-12 | Market Option Sale (Planned) | 100,000 | $5.66 | $566,000.00 | (100%) 100.0K to 0 | 94% |
| 29-May-12 2:17 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 25-May-12 | Purchase | 5,500 | -- | -- | 275% 2.0K to 7.5K | |
| 29-May-12 2:17 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 24-May-12 | Market Purchase | 2,000 | $13.55 | $27,101.60 | 100% 0 to 2.0K | 23% |